BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9777529)

  • 1. Reduction of Staphylococcus aureus nasal carriage and infection in dialysis patients.
    Herwaldt LA
    J Hosp Infect; 1998 Sep; 40 Suppl B():S13-23. PubMed ID: 9777529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention.
    Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
    J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection.
    Wenzel RP; Perl TM
    J Hosp Infect; 1995 Sep; 31(1):13-24. PubMed ID: 7499817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of nasal carriage of Staphylococcus aureus--is it cost-effective?
    Davey P
    J Hosp Infect; 1998 Sep; 40 Suppl B():S31-7. PubMed ID: 9777531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis.
    Bloom BS; Fendrick AM; Chernew ME; Patel P
    Am J Kidney Dis; 1996 May; 27(5):687-94. PubMed ID: 8629629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcus aureus carriage and infections among patients in four haemo- and peritoneal-dialysis centres in Denmark. The Danish Study Group of Peritonitis in Dialysis (DASPID).
    Zimakoff J; Bangsgaard Pedersen F; Bergen L; Baagø-Nielsen J; Daldorph B; Espersen F; Gahrn Hansen B; Høiby N; Jepsen OB; Joffe P; Kolmos HJ; Klausen M; Kristoffersen K; Ladefoged J; Olesen-Larsen S; Rosdahl VT; Scheibel J; Storm B; Tofte-Jensen P
    J Hosp Infect; 1996 Aug; 33(4):289-300. PubMed ID: 8864941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis.
    Chow JW; Yu VL
    Arch Intern Med; 1989 Jun; 149(6):1258-62. PubMed ID: 2658896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative decolonization of methicillin-resistant Staphylococcus aureus.
    Larkin SA; Murphy BS
    Orthopedics; 2008 Jan; 31(1):37-41. PubMed ID: 18269166
    [No Abstract]   [Full Text] [Related]  

  • 10. S. aureus nasal carriage: importance and approaches.
    Piraino B
    Perit Dial Int; 1995; 15(8):301-2. PubMed ID: 8785225
    [No Abstract]   [Full Text] [Related]  

  • 11. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.
    Yu VL; Goetz A; Wagener M; Smith PB; Rihs JD; Hanchett J; Zuravleff JJ
    N Engl J Med; 1986 Jul; 315(2):91-6. PubMed ID: 3523240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it possible to decrease the rate of Staphylococcus aureus peritonitis?
    Piraino B
    Perit Dial Int; 1996; 16(5):446-7. PubMed ID: 8914174
    [No Abstract]   [Full Text] [Related]  

  • 13. The in-vitro activity of povidone-iodinecream against Staphylococcus aureus and its bioavailability in nasal secretions.
    Hill RL; Casewell MW
    J Hosp Infect; 2000 Jul; 45(3):198-205. PubMed ID: 10896798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost Efficacy of Methicillin-Resistant Staphylococcus aureus Decolonization With Intranasal Povidone-Iodine.
    Rieser GR; Moskal JT
    J Arthroplasty; 2018 Jun; 33(6):1652-1655. PubMed ID: 29506927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus infections in dialysis patients: focus on prevention.
    Piraino B
    ASAIO J; 2000; 46(6):S13-7. PubMed ID: 11110288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin.
    Al-Hwiesh AK; Abdul Rahman IS
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcus aureus nasal carriage: role in continuous ambulatory peritoneal dialysis-associated infections.
    Herwaldt LA
    Perit Dial Int; 1993; 13 Suppl 2():S301-5. PubMed ID: 8399593
    [No Abstract]   [Full Text] [Related]  

  • 18. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients.
    Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA
    Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nose: an underestimated source of Staphylococcus aureus causing wound infection.
    Casewell MW
    J Hosp Infect; 1998 Sep; 40 Suppl B():S3-11. PubMed ID: 9777528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus nasal decolonization strategies: a review.
    Sakr A; Brégeon F; Rolain JM; Blin O
    Expert Rev Anti Infect Ther; 2019 May; 17(5):327-340. PubMed ID: 31012332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.